Repository

Publications

Perioperative approaches for patients with biliary tract cancer

Zorigtbaatar A, Li Z, Magyar CTJ, Aceituno L, Saborowski A, Vogel A, Grant RC, O'Kane GM, Sapisochin G.
Nat Rev Clin Oncol. 2026 Mar 3. doi: 10.1038/s41571-026-01130-5
2026 
Result from  

Health-related quality of life in biliary tract cancer clinical trials. The current state and future directions

Cavka L, Edeline J, Lamarca A
ESMO . 24 February 2026 . doi: 10.1016/j.esmogo.2026.100301
2026 
Result from  
Funded by  

Prognostic Impact of Metastatic Sites in Patients with Biliary Tract Cancer Treated with Cisplatin, Gemcitabine, and Durvalumab

Camera S, Fornaro L, Rimini M, Persano M, Rizzato MD, Saborowski A, Antonuzzo L, Rossari F, Satake T, Peeters F, Salani F, Bozzarelli S, Corallo S, Lucchetti J, Kim JW, Abidoye O, Rapposelli IG, Gallio C, Tamberi S, Finkelmeier F, Giordano G, Chiara P, Chon HJ, Braconi C, Qaisar A, Pastorino A, Castet F, Tamburini E, Yoo C, Parisi A, Diana A, Scartozzi M, Prager GW, Avallone A, Schirripa M, Kim IH, Perkhofer L, Oneda E, Verrico M, Couto N, Adeva J, Chan SL, Spinelli GP, Personeni N, Garajova I, Rodriquenz MG, Leo S, Melo Alvim C, Roque R, Farinea G, Genovesi V, De Rosa A, Lavacchi D, Lo Prinzi F, Passeri L, Ferrara M, Foti S, Ikeda M, Dekervel J, Niger M, Balsano R, Tonini G, Kang M, Tesini G, Esposito L, Casadio C, Himmelsbach V, Landriscina M, Ahcene Djaballah S, Bekaii-Saab T, Masi G, Vogel A, Lonardi S, Vivaldi C, Rimassa L, Casadei-Gardini A.
Target Oncol . 2026 Feb 27. doi: 10.1007/s11523-026-01200-9
2026 
Result from  

Perineural invasion is a prognostic factor in cholangiocarcinoma, regardless of anatomical location: a systematic review and meta-analysis: Perineural invasion in cholangiocarcinoma prognosis

Conti S, Tissera NS, Castet F, Basagaña-Farrés M, Teresa Salcedo M, Pando E, Dopazo C, Caritá L, Turpin A, Navarro GarcésV, Villacampa G,Macarulla T, Tian TV
JHEP Reports 5 February 2026, 101770, doi.org/10.1016/j.jhepr.2026.101770
2026 
Result from  

Uncovering the genetic landscape of cholangiocarcinoma and its subtypes via GWAS and integrative analyses

Han Y, Byun J, VanLith CJ, Cooley MA, Shaw VR, Hatia RI, Ahmed FY, Giama NH, Ali HM, Campbell NA, Hassan M, Andersen JB, Ankoma-Sey V, Banales JM, Bujanda L, Bathe OF, Bekaii-Saab TS, Borad MJ, Björkström NK, Chan CHF, Cleary SP, Cornillet M, Folseraas T, Galle PR, Genkinger JM, MacInnis RJ, Gores GJ, Goyal L, Houlston RS, Ilyas SI, Javle M, Johansen JS, Christensen TD, Kamath AS, Kelley RK, Khan SA, Kim RD, Kwee SA, Lamarca A, Lammert F, LaRusso NF, Lindsey S, Macias RIR, Malhi H, Patel TC, Permuth JB, Reeves HL, Rossi S, Sanchez W, Smoot RL, Swerdlow AJ, Tran Cao HS, Valle JW, Weinmann A, Weinmann-Menke J, Wong LL, Zhang X, Zimmer V, Zhu AX, Lazaridis KN, Juran BD, Jalal P, Knox JJ, Hutchinson A, Hicks B, Koshiol JE, Chanock SJ, Hassan MM, Amos CI, McGlynn KA, Roberts LR
Hepatology. 2026 Feb 2. doi: 10.1097/HEP.0000000000001699
2026 
Result from  
Join the Action
JOIN